logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Chiba University Hospital

Verified
+81432227171
morita.32018@chiba-u.jp
Source: Site record.
https://www.ho.chiba-u.ac.jp

Basic Information

Site Overview

Source: Human-provided.

As a clinical research site, Chiba University Hospital is a premier academic research institution in Japan with extensive experience in conducting Phase I–IV clinical trials across a broad range of therapeutic areas, including oncology, neurology, cardiology, immunology, infectious diseases, rare diseases, and regenerative medicine. Supported by a dedicated Clinical Research Center and experienced investigators, study coordinators, and research staff, the hospital conducts both investigator-initiated and industry-sponsored studies in compliance with international Good Clinical Practice (GCP) standards. Its large and diverse patient population, advanced diagnostic and treatment capabilities, strong regulatory expertise, and commitment to translational research make Chiba University Hospital a reliable partner for high-quality clinical trial execution and innovative medical research.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Human-provided. General hospital
Source: Human-provided. Hospital
Source: Trial-derived.
188Total Trials
Source: Trial-derived.
32Recruiting Trials
Source: Trial-derived.
82Active Trials
Source: Trial-derived.
85Completed Trials
Source: Trial-derived.
205Unique Conditions
Source: Trial-derived.
122Unique Sponsors

Conditions

Source: Trial-derived. Non-small Cell Lung Cancer (6)Source: Trial-derived. Carcinoma, Hepatocellular (5)Source: Trial-derived. Crohn's Disease (5)Source: Trial-derived. Hepatocellular Carcinoma (5)Source: Trial-derived. Obesity (5)Source: Trial-derived. Idiopathic Pulmonary Fibrosis (4)Source: Trial-derived. Multiple Myeloma (4)Source: Trial-derived. Amyotrophic Lateral Sclerosis (3)

Sponsors

Source: Trial-derived. Merck Sharp & Dohme LLC (24)Source: Trial-derived. AbbVie (19)Source: Trial-derived. Hoffmann-La Roche (12)Source: Trial-derived. Boehringer Ingelheim (11)Source: Trial-derived. Takeda (10)Source: Trial-derived. Chugai Pharmaceutical (9)Source: Trial-derived. Janssen Research & Development, LLC (8)Source: Trial-derived. Novo Nordisk A/S (6)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. Spirometry
Source: AI-inferred. Cardiac device interrogation and programming
Source: AI-inferred. Six-minute walk test
Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)
Source: AI-inferred. Optical coherence tomography (OCT)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Specimen packaging and shipment

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Liver biopsy
Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures
Source: AI-inferred. Cardiac implantable electronic device implantation
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Intravitreal injection
Source: AI-inferred. Surgery / operating room

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Grip strength dynamometry
Source: AI-inferred. Ophthalmologic examination
Source: AI-inferred. Autoinjector self-administration training
Source: AI-inferred. CAR-T cell therapy administration
Source: AI-inferred. Complement C2 (free and total) quantification
Source: AI-inferred. Complement C5 quantification
Source: AI-inferred. Complement hemolytic activity assay (CH50)
Source: AI-inferred. Cytokine testing